Marí Montserrat, Morales Albert, Colell Anna, García-Ruiz Carmen, Fernández-Checa Jose C
Department of Cell Death and Proliferation, Institute of Biomedical Research of Barcelona (IIBB-CSIC), Consejo Superior Investigaciones Científicas (CSIC), IDIBAPS, Liver Unit-Hospital Clínic, CIBEREHD, 08036 Barcelona, Spain.
Department of Cell Death and Proliferation, Institute of Biomedical Research of Barcelona (IIBB-CSIC), Consejo Superior Investigaciones Científicas (CSIC), IDIBAPS, Liver Unit-Hospital Clínic, CIBEREHD, 08036 Barcelona, Spain.
Redox Biol. 2014;3:100-8. doi: 10.1016/j.redox.2014.09.005. Epub 2014 Sep 28.
Alcoholic liver disease (ALD) is a major cause of chronic liver disease and a growing health concern in theworld. While the pathogenesis of ALD is poorly characterized key players identified in experimental models and patients, such as perturbations in mitochondrial structure and function, selective loss of antioxidant defense and susceptibility to inflammatory cytokines, contribute to ALD progression. Both oxidative stress and mitochondrial dysfunction compromise essential cellular functions and energy generation and hence are important pathogenic mechanisms of ALD. An important process mediating the mitochondrial disruption induced by alcohol intake is the trafficking of cholesterol to mitochondria, mediated by acid sphingomyelinase-induced endoplasmic reticulum stress, which contributes to increased cholesterol synthesis and StARD1upregulation. Mitochondrial cholesterol accumulation not only sensitizes to oxidative stress but it can contribute to the metabolic reprogramming in ALD, manifested by activation of the hypoxia inducible transcription factor 1 and stimulation of glycolysis and lactate secretion. Thus, a better understanding of the mechanisms underlying alcohol-mediated mitochondrial impairment and oxidative stress may lead to the identification of novel treatments for ALD. The present review briefly summarizes current knowledge on the cellular and molecular mechanisms contributing to alcohol-induced mitochondrial dysfunction and cholesterol accumulation and provides insights for potential therapeutic targets in ALD.
酒精性肝病(ALD)是慢性肝病的主要病因,且在全球范围内日益受到健康关注。虽然ALD的发病机制尚不明确,但在实验模型和患者中确定的关键因素,如线粒体结构和功能的紊乱、抗氧化防御的选择性丧失以及对炎性细胞因子的易感性,都促进了ALD的进展。氧化应激和线粒体功能障碍均损害细胞的基本功能和能量生成,因此是ALD的重要致病机制。介导酒精摄入引起的线粒体破坏的一个重要过程是胆固醇向线粒体的转运,这由酸性鞘磷脂酶诱导的内质网应激介导,导致胆固醇合成增加和类固醇生成急性调节蛋白1(StARD1)上调。线粒体胆固醇积累不仅会增加对氧化应激的敏感性,还会导致ALD中的代谢重编程,表现为缺氧诱导转录因子1的激活以及糖酵解和乳酸分泌的刺激。因此,更好地理解酒精介导的线粒体损伤和氧化应激的潜在机制,可能会带来针对ALD的新治疗方法。本综述简要总结了目前关于酒精诱导的线粒体功能障碍和胆固醇积累的细胞和分子机制的知识,并为ALD的潜在治疗靶点提供了见解。